Search research articles
Contact Us
Filters
Showing results (391-400 of 449) with videos related to
Page
of 45
Sort By:
Gynecologic Oncology
|
October 4, 2016
Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival in advanced stage ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study
Peter G Rose, James J Java, Mark A Morgan, et al.
Gynecologic Oncology
|
March 30, 2024
RETRACTED: Cost-effectiveness of chemotherapy and dostarlimab for advanced or recurrent endometrial cancer
Courtney J Riedinger, David A Barrington, Christa I Nagel, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 11, 2025
Expanding the workforce of clinical trial investigators committed to gynecologic cancer research: the GOG Foundation, Inc's Scholar Career Development Award and New Investigator Program
Angeles Alvarez Secord, Ronald D Alvarez, Leslie M Randall, et al.
American Journal of Obstetrics and Gynecology
|
December 27, 2022
Postoperative venous thromboembolism risk stratification in patients with uterine cancer
Vincent M Wagner, Rachael N Piver, Monica D Levine, et al.
Gynecologic Oncology Reports
|
March 13, 2023
Use of the Khorana score to predict venous thromboembolism in patients undergoing chemotherapy for uterine cancer
Rachael N Piver, Vincent M Wagner, Monica D Levine, et al.
Gynecologic Oncology
|
July 17, 2021
Phase I evaluation of lenvatinib and weekly paclitaxel in patients with recurrent endometrial, ovarian, fallopian tube, or primary peritoneal Cancer
Floor J Backes, Lai Wei, Min Chen, et al.
Journal of Cancer Survivorship : Research and Practice
|
January 24, 2024
Changes in prospectively collected patient-reported outcomes among women with incident endometrial cancer
Jennifer A Sinnott, Elaheh Torkashvand, Caitlin E Meade, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 13, 2015
Evaluation of the Hematologic Safety of Same Day Versus Standard Administration (24- to 72-Hour Delay) of Pegfilgrastim in Gynecology Oncology Patients Undergoing Cytotoxic Chemotherapy
Caroline C Billingsley, Samuel N Jacobson, Sarah M Crafton, et al.
Gynecologic Oncology
|
October 12, 2016
Does time interval between surgery and intraperitoneal chemotherapy administration in advanced ovarian cancer carry a prognostic impact? An NRG Oncology/Gynecologic Oncology Group study ancillary study
Arlene E Garcia-Soto, James J Java, Wilberto Nieves Neira, et al.
Journal of Minimally Invasive Gynecology
|
January 19, 2016
A Prospective, Comparative Study for the Evaluation of Postoperative Pain and Quality of Recovery in Patients Undergoing Robotic Versus Open Hysterectomy for Staging of Endometrial Cancer
David E Cohn, Karina Castellon-Larios, Laura Huffman, et al.
Page
of 45
Search research articles
Search
Showing results (391-400 of 449) with videos related to
Sort By:
Page
of 45
Gynecologic Oncology
|
October 4, 2016
Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival in advanced stage ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study
Peter G Rose, James J Java, Mark A Morgan, et al.
Gynecologic Oncology
|
March 30, 2024
RETRACTED: Cost-effectiveness of chemotherapy and dostarlimab for advanced or recurrent endometrial cancer
Courtney J Riedinger, David A Barrington, Christa I Nagel, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 11, 2025
Expanding the workforce of clinical trial investigators committed to gynecologic cancer research: the GOG Foundation, Inc's Scholar Career Development Award and New Investigator Program
Angeles Alvarez Secord, Ronald D Alvarez, Leslie M Randall, et al.
American Journal of Obstetrics and Gynecology
|
December 27, 2022
Postoperative venous thromboembolism risk stratification in patients with uterine cancer
Vincent M Wagner, Rachael N Piver, Monica D Levine, et al.
Gynecologic Oncology Reports
|
March 13, 2023
Use of the Khorana score to predict venous thromboembolism in patients undergoing chemotherapy for uterine cancer
Rachael N Piver, Vincent M Wagner, Monica D Levine, et al.
Gynecologic Oncology
|
July 17, 2021
Phase I evaluation of lenvatinib and weekly paclitaxel in patients with recurrent endometrial, ovarian, fallopian tube, or primary peritoneal Cancer
Floor J Backes, Lai Wei, Min Chen, et al.
Journal of Cancer Survivorship : Research and Practice
|
January 24, 2024
Changes in prospectively collected patient-reported outcomes among women with incident endometrial cancer
Jennifer A Sinnott, Elaheh Torkashvand, Caitlin E Meade, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 13, 2015
Evaluation of the Hematologic Safety of Same Day Versus Standard Administration (24- to 72-Hour Delay) of Pegfilgrastim in Gynecology Oncology Patients Undergoing Cytotoxic Chemotherapy
Caroline C Billingsley, Samuel N Jacobson, Sarah M Crafton, et al.
Gynecologic Oncology
|
October 12, 2016
Does time interval between surgery and intraperitoneal chemotherapy administration in advanced ovarian cancer carry a prognostic impact? An NRG Oncology/Gynecologic Oncology Group study ancillary study
Arlene E Garcia-Soto, James J Java, Wilberto Nieves Neira, et al.
Journal of Minimally Invasive Gynecology
|
January 19, 2016
A Prospective, Comparative Study for the Evaluation of Postoperative Pain and Quality of Recovery in Patients Undergoing Robotic Versus Open Hysterectomy for Staging of Endometrial Cancer
David E Cohn, Karina Castellon-Larios, Laura Huffman, et al.
Page
of 45